Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 647

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Open access
Patel, Anoop P, Fisher, James L, Nichols, Emma, Abd-Allah, Foad, Abdela, Jemal, Abdelalim, Ahmed, Abraha, Haftom Niguse, Agius, Dominic, Alahdab, Fares, Alam, Tahiya, Allen, Christine A, Anber, Nahla Hamed, Awasthi, Ashish, Badali, Hamid, Belachew, Abate Bekele, Bijani, Ali, Bjørge, Tone, Carvalho, Félix, Catalá-López, Ferrán, Choi, Jee-Young J, Daryani, Ahmad, Degefa, Meaza Girma, Demoz, Gebre Teklemariam, Do, Huyen Phuc, Dubey, Manisha, Fernandes, Eduarda, Filip, Irina, Foreman, Kyle J, Gebre, Abadi Kahsu, Geramo, Yilma Chisha Dea, Hafezi-Nejad, Nima, Hamidi, Samer, Harvey, James D, Hassen, Hamid Yimam, Hay, Simon I, Irvani, Seyed Sina Naghibi, Jakovljevic, Mihajlo, Jha, Ravi Prakash, Kasaeian, Amir, Khalil, Ibrahim A, Khan, Ejaz Ahmad, Khang, Young-Ho, Kim, Yun Jin, Mengistu, Getnet, Mohammad, Karzan Abdulmuhsin, Mokdad, Ali H, Nagel, Gabriele, Naghavi, Mohsen, Naik, Gurudatta, Nguyen, Huong Lan Thi, Nguyen, Long Hoang, Nguyen, Trang Huyen, Nixon, Molly R, Olagunju, Andrew T, Pereira, David M, Pinilla-Monsalve, Gabriel David, Poustchi, Hossein, Qorbani, Mostafa, Radfar, Amir, Reiner, Robert C, Roshandel, Gholamreza, Safari, Hosein, Safiri, Saeid, Samy, Abdallah M, Sarvi, Shahabeddin, Shaikh, Masood Ali, Sharif, Mehdi, Sharma, Rajesh, Sheikhbahaei, Sara, Shirkoohi, Reza, Singh, Jasvinder A, Smith, Mari, Tabarés-Seisdedos, Rafael, Tran, Bach Xuan, Tran, Khanh Bao, Ullah, Irfan, Weiderpass, Elisabete, Weldegwergs, Kidu Gidey, Yimer, Ebrahim M, Zadnik, Vesna, Zaidi, Zoubida, Ellenbogen, Richard G, Vos, Theo, Feigin, Valery L, Murray, Christopher J L, Fitzmaurice, Christina·2019·The Lancet Neurology

Abstract

BACKGROUND: Brain and CNS cancers (collectively referred to as CNS cancers) are a source of mortality and morbidity for which diagnosis and treatment require extensive resource allocation and sophisticated diagnostic and therapeutic technology. Previous epidemiological studies are limited to specific geographical regions or time periods, making them difficult to compare on a global scale. In this analysis, we aimed to provide a comparable and comprehensive estimation of the global burden of brain cancer between 1990 and 2016. METHODS: We report means and 95% uncertainty intervals (UIs) for incidence, mortality, and disability-adjusted life-years (DALYs) estimates for CNS cancers (according to the International Classification of Diseases tenth revision: malignant neoplasm of meninges, malignant neoplasm of brain, and malignant neoplasm of spinal cord, cranial nerves, and other parts of CNS) from the Global Burden of Diseases, Injuries, and Risk Factors Study 2016. Data sources include vital registration and cancer registry data. Mortality was modelled using an ensemble model approach. Incidence was estimated by dividing the final mortality estimates by mortality to incidence ratios. DALYs were estimated by summing years of life lost and years lived with disability. Locations were grouped into quintiles based on the Socio-demographic Index (SDI), a summary indicator of income per capita, years of schooling, and total fertility rate. FINDINGS: In 2016, there were 330 000 (95% UI 299 000 to 349 000) incident cases of CNS cancer and 227 000 (205 000 to 241 000) deaths globally, and age-standardised incidence rates of CNS cancer increased globally by 17·3% (95% UI 11·4 to 26·9) between 1990 and 2016 (2016 age-standardised incidence rate 4·63 per 100 000 person-years [4·17 to 4·90]). The highest age-standardised incidence rate was in the highest quintile of SDI (6·91 [5·71 to 7·53]). Age-standardised incidence rates increased with each SDI quintile. East Asia was the region with the most incident cases of CNS cancer for both sexes in 2016 (108 000 [95% UI 98 000 to 122 000]), followed by western Europe (49 000 [37 000 to 54 000]), and south Asia (31 000 [29 000 to 37 000]). The top three countries with the highest number of incident cases were China, the USA, and India. CNS cancer was responsible for 7·7 million (95% UI 6·9 to 8·3) DALYs globally, a non-significant change in age-standardised DALY rate of -10·0% (-16·4 to 2·6) between 1990 and 2016. The age-standardised DALY rate decreased in the high SDI quintile (-10·0% [-27·1 to -0·1]) and high-middle SDI quintile (-10·5% [-18·4 to -1·4]) over time but increased in the low SDI quintile (22·5% [11·2 to 50·5]). INTERPRETATION: CNS cancer is responsible for substantial morbidity and mortality worldwide, and incidence increased between 1990 and 2016. Significant geographical and regional variation in the incidence of CNS cancer might be reflective of differences in diagnoses and reporting practices or unknown environmental and genetic risk factors. Future efforts are needed to analyse CNS cancer burden by subtype. FUNDING: Bill & Melinda Gates Foundation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(18)30468-x

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 647

Metadata

Authors
Patel, A. P., Fisher, J. L., Nichols, E., Abd-Allah, F., Abdela, J., Abdelalim, A., Abraha, H. N., Agius, D., Alahdab, F., Alam, T., Allen, C. A., Anber, N. H., Awasthi, A., Badali, H., Belachew, A. B., Bijani, A., Bjørge, T., Carvalho, F., Catalá-López, F., Choi, J.-Y. J., Daryani, A., Degefa, M. G., Demoz, G. T., Do, H. P., Dubey, M., Fernandes, E., Filip, I., Foreman, K. J., Gebre, A. K., Geramo, Y. C. D., Hafezi-Nejad, N., Hamidi, S., Harvey, J. D., Hassen, H. Y., Hay, S. I., Irvani, S. S. N., Jakovljevic, M., Jha, R. P., Kasaeian, A., Khalil, I. A., Khan, E. A., Khang, Y.-H., Kim, Y. J., Mengistu, G., Mohammad, K. A., Mokdad, A. H., Nagel, G., Naghavi, M., Naik, G., Nguyen, H. L. T., Nguyen, L. H., Nguyen, T. H., Nixon, M. R., Olagunju, A. T., Pereira, D. M., Pinilla-Monsalve, G. D., Poustchi, H., Qorbani, M., Radfar, A., Reiner, R. C., Roshandel, G., Safari, H., Safiri, S., Samy, A. M., Sarvi, S., Shaikh, M. A., Sharif, M., Sharma, R., Sheikhbahaei, S., Shirkoohi, R., Singh, J. A., Smith, M., Tabarés-Seisdedos, R., Tran, B. X., Tran, K. B., Ullah, I., Weiderpass, E., Weldegwergs, K. G., Yimer, E. M., Zadnik, V., Zaidi, Z., Ellenbogen, R. G., Vos, T., Feigin, V. L., Murray, C. J. L., & Fitzmaurice, C.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2019-04
Volume
18
Issue
4
Pages
376-393
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2916892496
Cited by
647
References
35
FWCI
28.75
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. https://app.cochat.ai/papers/10.1016/s1474-4422(18)30468-x
The paper
Patel, A. P., Fisher, J. L., Nichols, E., Abd-Allah, F., Abdela, J., Abdelalim, A., Abraha, H. N., Agius, D., Alahdab, F., Alam, T., Allen, C. A., Anber, N. H., Awasthi, A., Badali, H., Belachew, A. B., Bijani, A., Bjørge, T., Carvalho, F., Catalá-López, F., . . . Fitzmaurice, C. (2019). Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(18)30468-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.